Stockholders' Equity (Tables)

3 Months Ended

Dec. 31, 2020

Equity [Abstract]

Schedule of Stock-Based Compensation Expense Related to Stock Options and RSUs

The following table summarizes stock-based compensation expense related to RSUs, stock options, and ESPP shares, which was allocated as follows (amounts shown in thousands):

	Three Months Ended December 31,
	2020		2019
Cost of revenue	$	87	$	61
Selling and marketing	788		572
Research and development	740		674
General and administrative	1,132		996
Stock-based compensation expense included in expenses	$	2,747	$	2,303

Schedule of Stock Option Activity

The following table summarizes stock option activity under the Company’s equity plans during the three months ended December 31, 2020:

	Number of Shares	Weighted-Average Exercise Price		Weighted-Average Remaining Contractual Term (in Years)	Aggregate Intrinsic Value (in thousands)
Outstanding at September 30, 2020	1,162,505	$	7.51	6.1	$	6,081
Granted	—	$	—
Exercised	(241,490)	$	7.82
Canceled	—	$	—
Outstanding at December 31, 2020	921,015	$	7.43	6.2	$	9,536
Vested and Expected to Vest at December 31, 2020	921,015	$	7.43	6.2	$	9,536
Exercisable at December 31, 2020	585,487	$	6.25	5.1	$	6,750

Schedule of RSU Activity

The following table summarizes RSU activity under the Company’s equity plans during the three months ended December 31, 2020:

	Number of Shares	Weighted-Average Fair Market Value Per Share
Outstanding at September 30, 2020	2,661,943	$	7.95
Granted	647,052	$	11.92
Settled	(647,035)	$	7.32
Canceled	(34,135)	$	8.39
Outstanding at December 31, 2020	2,627,825	$	9.07

Schedule of Performance RSU Activity

Performance Restricted Stock Units

The following table summarizes Performance RSU activity under the Company’s equity plans during the three months ended December 31, 2020:

	Number of Shares	Weighted-Average Fair Market Value Per Share
Outstanding at September 30, 2020	353,556	$	6.06
Granted	284,765	$	11.84
Settled	—	$	—
Canceled	—	$	—
Outstanding at December 31, 2020	638,321	$	8.64